METHODS:
We conducted a series of 5 cross-sectional studies in 1994 to 1995 (prevaccine), 2000, 2003, 2006, and 2009 in Kaiser Permanente of Northern California to assess changes in varicella epidemiology in children and adolescents, as well as changes in varicella hospitalization in people of all ages. For each study, information on varicella history and varicella occurrence during the past year was obtained by telephone survey from a sample of ∼8000 members 5 to 19 years old; varicella hospitalization rates were calculated for the entire membership.
RESULTS:
Between 1995 and 2009, the overall incidence of varicella in 5-to 19-year-olds decreased from 25.8 to 1.3 per 1000 person-years, a ∼90% to 95% decline in the various age categories (5-9, 10-14, and 15-19 years of age). The proportion of varicella-susceptible children and adolescents also decreased in all age groups, including in 15-to 19-year-olds (from 15.6% in 1995 to 7.6% in 2009). From 1994 to 2009, age-adjusted varicella hospitalization rates in the general member population decreased from 2.13 to 0.25 per 100 000, a ∼90% decline.
CONCLUSIONS:
In the 15 years after the introduction of varicella vaccine, a major reduction in varicella incidence and hospitalization was observed with no evidence of a shift in the burden of varicella to older age groups. In the prevaccine era, varicella-zoster virus (VZV) was associated with nearly universal infection, with the highest incidence of disease in children younger than 10 years of age. 1, 2 Varicella was generally considered a relatively benign disease in young healthy children, though it accounted for significant hospitalizations (∼11 000-13 000 annually) and ∼100 to 150 deaths every year, in all ages, in the United States. Morbidity from varicella was considerably worse in older teenagers and adults. 3 There were concerns, at the time of vaccine licensure in 1995, that decreased exposure to circulating VZV due to vaccination of only young children could increase the number of adolescents susceptible to varicella and shift the incidence of the disease to older age groups, where more severe disease might be more common. Such a shift in age was seen with mumps, for example, where prevaccine era incidence was higher in children 5 to 9 years of age, but then cases shifted to those older than 15 years of age after widespread immunization. 4 Indeed, after varicella vaccination implementation, a shift of the age distribution of varicella cases toward older age groups was observed in children and adolescents, 5 although varicella incidence rates decreased in all age groups. In addition, a mathematical model published in 1994 suggested that partial varicella vaccine coverage of the population had the potential to increase the incidence of varicella among adolescents and adults, even if it resulted in a decrease in the incidence of varicella in children. 6 Varivax [8] [9] [10] leading to a recommendation for a second dose of the vaccine at 4 to 6 years of age by the ACIP in 2006. 11 Recent studies have revealed that varicella incidence has declined further since implementation of the second dose 12, 13 and effectiveness of the 2-dose series has been estimated to be as high as 98%, 14 confirming findings from clinical trials. 15 In a previous cohort study conducted from 1995 to 2009, we reported an effectiveness of ∼90% over 14 years postvaccination for the first dose, with no cases noted after the second dose. 16 In light of concerns about disease shifts, we conducted a series of 5 cross-sectional surveys in 1995 (prevaccine), 2000, 2003, 2006, and 2009 to examine the changes in the epidemiology of varicella in children and adolescents over a period of ∼15 years after the introduction of the varicella vaccine. We also examined changes in the incidence of varicella-associated hospitalization in all age groups of the population over this time period.
METHODS

Setting
The study was conducted were sampled from those who were continuously enrolled at KPNC (ie, without any gap in KPNC membership) from 1995 (when the vaccine was first available at KPNC) or birth, whichever was later, until the time of the survey. Trained telephone interviewers surveyed study participants (when living independently) or parents/guardians, using a structured, standardized questionnaire to obtain information about the occurrence of varicella in the past year (varicella incidence) and whether the study participant had ever had varicella before the survey year (varicella history). To ensure greater consistency of response across age categories, interviewers attempted to interview parents/guardians, even if the children were older adolescents. No medical confirmation of the diagnosis of varicella was required. Information on ARTICLE varicella vaccination status was ascertained via the telephone survey in 1995 or via the KPNC immunization database for the subsequent surveys.
In addition to the cross-sectional surveys of children and adolescents, to assess the impact of childhood varicella vaccination, either directly or due to herd immunity, on the incidence and severity of varicella in the general pediatric and adult population, we measured changes in varicella-associated hospitalization rates in the entire KPNC population (including all age groups) by using computerized hospital records. 
Data Analysis
Two time periods were considered for each participating child oradolescent: the 12-month period preceding the interview (the survey year) and the entire period before the survey year (ie, before the 12-month period preceding the interview).
Annual incidence rates of parent-or selfreported varicella were determined as theratioofthenumberofcasesofvaricella reported during the survey year among children and adolescents in a given age categoryover theperson-timecontributed by all individuals in that age category. For this calculation, each surveyed member contributed1yearofperson-timetoanage category, corresponding to the 1-year survey period in which the occurrence of varicella was queried.
For each age category, vaccination coverage was determined as the proportion of children and adolescents surveyed in that age category who had a recorded varicella vaccination before the interview. History of varicella was based on parental or self-report of varicella before the survey year. Children or adolescents with a reported case of varicella in the survey year were systematically classified as varicella history negative before the report of varicella. To track changes in those children without any protection from varicella, we defined a child or adolescent as "varicella-unprotected" in the absence of either a history of varicella before the survey year or a record of varicella vaccination before the interview.
Varicella-associated hospitalizations were identified through the presence of a diagnosis code of varicella (International Classification of Diseases, Ninth Revision code 052.3) listed as a primary diagnosis among hospital discharge diagnosis codes, as in previous studies. 18 The hospital diagnosis of varicella in adults older than 60 years of age was confirmed by medical record review. Person-time was calculated by multiplying the number of members by 1 year. Hospitalization rates were presented both as age-specific rates and overall rates age-adjusted to the year 2000 KPNC population distribution. Poisson regression was used to assess changes in hospitalization rates over time while adjusting for age.
RESULTS
Study Sample
Between May and November of each survey year, of the ∼9400 to 10 400 people contacted, ∼8400 to 8900 (82%-95%) KPNC members 5 to 19 years of age were eligible and completed the telephone survey. Those who could not complete the survey included ∼200 to 1100 (2%-11%) who were not reachable, ∼250 to 800 (3%-8%) who refused to participate, and ∼50 (0.5%) who were not eligible. Reasons for ineligibility included language barriers and individuals who were deceased, in foster care, or traveling out of state.
Demographics
Across the study years, the sample population was well-balanced with respect to gender ( Table 1) . Most (96.5%) of the sample population attended day care or school. Over the years, the proportions of the Asian, Hispanic, and white participants in the study samples were relatively stable, whereas there was a slight decrease of African Americans and a slight increase of multiracial participants. The majority of parents/guardians had more than a high school education.
Varicella Vaccination Coverage
From 2000 to 2009, varicella vaccination coverage increased rapidly from 51% to 98.8% in the 5-to 9-yearage group, 11% to 94.7% in the 10-to 14-year age group, and 3% to 53.6% in the 15-to 19-year age group, respectively. In the 2009 survey, 90.6% of all history-negative children and adolescents 5 to 19 years of age were recorded as being vaccinated, with an even higher proportion (99.3% and 98.5%) among the 5-to 9-year age group and 10-to 14-yearage group, respectively. These findings suggest that vaccination coverage was high in the younger age groups and that catch-up vaccination programshavebeeneffectiveatreaching susceptible children and adolescents.
Unvaccinated Children Without Varicella Over Time
The Varicella Incidence Rates Over Time Table 3 summarizes the reported annual varicella incidence rates in the 5-to 9-, 10-to 14-, and 15-to 19-year age groups for the 5 surveys.
The incidence rates of reported varicella declined significantly in all age categories since varicella vaccination was introduced in 1995. The rate of reported varicella in the 5-to 9-year age group in 2009 was 4% of the rate in 1995, a 96% reduction in disease incidence. In the 10-to 14-year age group, the incidence of reported varicella in 2009 was 9% of that in 1995, a 91% reduction in disease incidence. reported by the Centers for Disease Control and Prevention from US surveillance systems 5, 19, 20 and in published surveillance data from Europe. 21, 22 In the 2009 survey, varicella vaccine coverage at KPNC was high among young children and adolescents because of high compliance with vaccine recommendations, and a successful catch-up program in history-negative teenagers. As a result, few children and adolescents were still without any protection from varicella in 2009. 
FIGURE 1
Rates of hospitalization with a primary diagnosis for varicella at KPNC, by age group, 1994-2009. This study has a number of limitations. Although parental report of varicella history has been shown to be reliable for young children, history of varicella as reported by parents/guardians or the subject may be less reliable in adolescents, and for younger children as varicella becomes less common. 27, 28 The accuracy of a report of varicella in the past year may also be subject to recall bias, especially if the case of varicella occurred earlier in that time period. In addition, as varicella disease has become rare and much milder in the vaccine era, parents may have been less able over time to accurately recognize a varicella case. In parallel, varicella hospitalization rates decreased by ∼90% in all age categories between 1994 and 2009, emphasizing the impact of the varicella vaccination program in all age groups, including adolescents and adults. This study confirms that varicella vaccination has the ability to dramatically decrease varicella burden, both directly and possibly through herd immunity.
